Skip to main content
Premium Trial:

Request an Annual Quote

GenomeQuest, Pathogenica Partner on Services for Infectious Disease Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenomeQuest and Pathogenica today announced a partnership to offer discovery services in infectious disease research.

The deal combines Pathogenica's technology for detecting and sub-selecting pathogen genomes in human tissue with GenomeQuest's large-scale whole genome, exome, and microbiome analysis. Services to be offered include research into the interaction between the human microbiome and human genome, the firms said.

GenomeQuest and Pathogenica will immediately begin work on target selection, assay customization, and validation studies, they said.

Target applications will span basic research through clinical trial endpoint evaluation and focus on infection therapeutics in which the genotypes of both the pathogen and human affect the treatment outcome. Applications of the research-use only offerings include viral drug resistance studies in pre-clinical and clinical development; and co-sequencing of viral drug resistance mutations and human exome samples to predict drug response.

They also include custom infectious disease assays combined with deep sequencing and analysis for the identification of mutant infectious strains in human and mouse samples; and development of biomarkers for infectious disease.

Financial and other terms of the deal were not disclosed.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.